Transcaval embolization as the preferred approach

Caroline G. Burley, Mark H. Kumar, Waseem A. Bhatti, Christina Boyd, Clifford M. Sales

Research output: Contribution to journalArticle

Abstract

The management of type II endoleaks that develop after endovascular repair of aortic aneurysms now includes the transcaval approach. We reviewed the safety and efficacy of this technique in 10 consecutive patients (82 ± 7 years old; 80% male) who presented with a mean sac enlargement of 1.2 ± 0.7 cm and documented flow within the aortic sac. Patients presented a mean of 5.5 ± 3.1 years after endovascular aneurysm repair, and five (50%) patients had prior attempts at endovascular repair of the documented endoleak. Patients underwent a percutaneous transcaval approach to the aorta with use of the Rösch-Uchida Transjugular Liver Access Kit (Cook Medical, Bloomington, Ind) through an 8F sheath in a biplane angiography room. Coil embolization of the sac and lumbar arteries and occasional use of gelatin granules and human thrombin slurry allowed obliteration of the endoleak. No complications developed. Nine patients (90%) were noted to have a decreased sac diameter on the postprocedure study, and only one (10%) had persistent (but markedly diminished) flow noted on the follow-up ultrasound examination. Follow-up is early and extends to 6 months without recurrence of the endoleaks. The ability to safely access the aortic sac through the vena cava is a potentially efficient, safe, and useful technique to treat aortic endoleaks.

Original languageEnglish (US)
Pages (from-to)1309-1313
Number of pages5
JournalJournal of Vascular Surgery
Volume69
Issue number4
DOIs
StatePublished - Apr 1 2019
Externally publishedYes

Fingerprint

Endoleak
Venae Cavae
Aortic Aneurysm
Gelatin
Thrombin
Aneurysm
Aorta
Angiography
Arteries
Safety
Recurrence
Liver

All Science Journal Classification (ASJC) codes

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Burley, Caroline G. ; Kumar, Mark H. ; Bhatti, Waseem A. ; Boyd, Christina ; Sales, Clifford M. / Transcaval embolization as the preferred approach. In: Journal of Vascular Surgery. 2019 ; Vol. 69, No. 4. pp. 1309-1313.
@article{655b846e37e24bcfb539122678db51e4,
title = "Transcaval embolization as the preferred approach",
abstract = "The management of type II endoleaks that develop after endovascular repair of aortic aneurysms now includes the transcaval approach. We reviewed the safety and efficacy of this technique in 10 consecutive patients (82 ± 7 years old; 80{\%} male) who presented with a mean sac enlargement of 1.2 ± 0.7 cm and documented flow within the aortic sac. Patients presented a mean of 5.5 ± 3.1 years after endovascular aneurysm repair, and five (50{\%}) patients had prior attempts at endovascular repair of the documented endoleak. Patients underwent a percutaneous transcaval approach to the aorta with use of the R{\"o}sch-Uchida Transjugular Liver Access Kit (Cook Medical, Bloomington, Ind) through an 8F sheath in a biplane angiography room. Coil embolization of the sac and lumbar arteries and occasional use of gelatin granules and human thrombin slurry allowed obliteration of the endoleak. No complications developed. Nine patients (90{\%}) were noted to have a decreased sac diameter on the postprocedure study, and only one (10{\%}) had persistent (but markedly diminished) flow noted on the follow-up ultrasound examination. Follow-up is early and extends to 6 months without recurrence of the endoleaks. The ability to safely access the aortic sac through the vena cava is a potentially efficient, safe, and useful technique to treat aortic endoleaks.",
author = "Burley, {Caroline G.} and Kumar, {Mark H.} and Bhatti, {Waseem A.} and Christina Boyd and Sales, {Clifford M.}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.jvs.2018.08.177",
language = "English (US)",
volume = "69",
pages = "1309--1313",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "4",

}

Transcaval embolization as the preferred approach. / Burley, Caroline G.; Kumar, Mark H.; Bhatti, Waseem A.; Boyd, Christina; Sales, Clifford M.

In: Journal of Vascular Surgery, Vol. 69, No. 4, 01.04.2019, p. 1309-1313.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transcaval embolization as the preferred approach

AU - Burley, Caroline G.

AU - Kumar, Mark H.

AU - Bhatti, Waseem A.

AU - Boyd, Christina

AU - Sales, Clifford M.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The management of type II endoleaks that develop after endovascular repair of aortic aneurysms now includes the transcaval approach. We reviewed the safety and efficacy of this technique in 10 consecutive patients (82 ± 7 years old; 80% male) who presented with a mean sac enlargement of 1.2 ± 0.7 cm and documented flow within the aortic sac. Patients presented a mean of 5.5 ± 3.1 years after endovascular aneurysm repair, and five (50%) patients had prior attempts at endovascular repair of the documented endoleak. Patients underwent a percutaneous transcaval approach to the aorta with use of the Rösch-Uchida Transjugular Liver Access Kit (Cook Medical, Bloomington, Ind) through an 8F sheath in a biplane angiography room. Coil embolization of the sac and lumbar arteries and occasional use of gelatin granules and human thrombin slurry allowed obliteration of the endoleak. No complications developed. Nine patients (90%) were noted to have a decreased sac diameter on the postprocedure study, and only one (10%) had persistent (but markedly diminished) flow noted on the follow-up ultrasound examination. Follow-up is early and extends to 6 months without recurrence of the endoleaks. The ability to safely access the aortic sac through the vena cava is a potentially efficient, safe, and useful technique to treat aortic endoleaks.

AB - The management of type II endoleaks that develop after endovascular repair of aortic aneurysms now includes the transcaval approach. We reviewed the safety and efficacy of this technique in 10 consecutive patients (82 ± 7 years old; 80% male) who presented with a mean sac enlargement of 1.2 ± 0.7 cm and documented flow within the aortic sac. Patients presented a mean of 5.5 ± 3.1 years after endovascular aneurysm repair, and five (50%) patients had prior attempts at endovascular repair of the documented endoleak. Patients underwent a percutaneous transcaval approach to the aorta with use of the Rösch-Uchida Transjugular Liver Access Kit (Cook Medical, Bloomington, Ind) through an 8F sheath in a biplane angiography room. Coil embolization of the sac and lumbar arteries and occasional use of gelatin granules and human thrombin slurry allowed obliteration of the endoleak. No complications developed. Nine patients (90%) were noted to have a decreased sac diameter on the postprocedure study, and only one (10%) had persistent (but markedly diminished) flow noted on the follow-up ultrasound examination. Follow-up is early and extends to 6 months without recurrence of the endoleaks. The ability to safely access the aortic sac through the vena cava is a potentially efficient, safe, and useful technique to treat aortic endoleaks.

UR - http://www.scopus.com/inward/record.url?scp=85063024466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063024466&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2018.08.177

DO - 10.1016/j.jvs.2018.08.177

M3 - Article

C2 - 30905367

AN - SCOPUS:85063024466

VL - 69

SP - 1309

EP - 1313

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 4

ER -